What You Should Know
- The Deployment: Brainomix has officially rolled out its AI imaging platform, Brainomix 360 Stroke, across all 25 sites of the West Virginia University (WVU) Health System.
- The Technology: The fully automated AI platform analyzes CT, CTA, CTP, and MRI scans in real-time. It provides clinicians with critical, objective insights—such as detecting large-vessel occlusions (LVOs) and assessing ischemic core volume—to accelerate treatment and transfer decisions.
- The Clinical Goal: The system-wide deployment aims to eliminate geographic disparities in stroke care. A patient arriving at a small regional community hospital will now receive the exact same level of expert AI stroke assessment as a patient arriving at WVU’s flagship academic medical center.
- The Market Context: Originally a spin-out from the University of Oxford, Brainomix has been rapidly expanding its U.S. footprint. Recent clinical studies have shown that implementing the platform can increase mechanical thrombectomy rates by over 50%, significantly improving patient functional independence.
Standardizing the Imaging Workflow
Historically, assessing a non-contrast CT (NCCT) or a CT angiogram (CTA) in a rural community hospital meant relying on on-call radiologists who may not specialize in complex neurovascular events. This variability in imaging interpretation often leads to delayed transfers or missed treatment windows.
Brainomix 360 Stroke automates this process. The platform ingests the scans and utilizes FDA-cleared algorithms to instantly identify suspected large-vessel occlusions (LVOs), calculate ASPECTS scores, and estimate ischemic core volumes.
“WVU Medicine is committed to advancing patient care through technologies that support clinical decision making and improve the patient experience,” said Charles J. Barkey, Vice President of Information Technology for Northern Panhandle WVU Medicine Hospitals. “As part of this effort, we recently implemented Brainomix’s AI imaging platform across our network to help reduce time to treatment for potentially critical stroke types.”
The Enterprise Value Beyond the Scan
While the clinical benefits of preventing long-term stroke disability are paramount, the operational and financial implications for a health system of WVU’s size are equally profound. When a hub-and-spoke hospital network utilizes a fragmented patchwork of imaging tools, it creates massive friction. Patient transfers are delayed, Electronic Health Record (EHR) documentation becomes disjointed, and the revenue cycle suffers from missed acuity capture and delayed billing.
WVU is streamlining the complex logistics of patient transfers deplying all 25 sites under the Brainomix architecture. The AI not only complements existing telestroke services, but it ensures that the receiving comprehensive stroke center has immediate, standardized, and highly accurate diagnostic data the moment the patient arrives. This seamless data fluidity reduces administrative burden, ensures accurate coding, and ultimately maximizes the health system’s ability to deliver high-value, high-acuity care.
